0.4607

15.46% 0.0617

Bionexus Gene Lab Corp (BGLC)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$0.399

Offen:

$0.372

24-Stunden-Volumen:

7.25M

Relative Volume:

1.99

Marktkapitalisierung:

$8.28M

Einnahmen:

$10.34M

Nettoeinkommen (Verlust:

$-3.09M

KGV:

-1.6875

EPS:

-0.273

Netto-Cashflow:

$-736.20K

1W Leistung:

+72.35%

1M Leistung:

+50.11%

6M Leistung:

-2.54%

1J Leistung:

+0.00%

1-Tages-Spanne:

$0.372

$0.525

1-Wochen-Bereich:

$0.26

$0.84

52-Wochen-Spanne:

$0.2105

$3.39

Bionexus Gene Lab Corp Stock (BGLC) Company Profile

Firmenname

Bionexus Gene Lab Corp

Sektor

Basic Materials (269)

Branche

Specialty Chemicals (56)

Telefon

1-307-241-6898

Adresse

10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

BGLC's Discussions on Twitter

Vergleichen Sie BGLC mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BGLC BioNexus Gene Lab Corp Common stock	1.14	201.51M	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	0.29	612.00M	2.07B	-1.42B	-1.37B	-0.6765
GOODO Gladstone Commercial Corporation	20.65	372.90M	0	0	0	0.00
MOBBW Mobilicom Limited Warrants	0.82	278.60M	0	0	0	0.00
SHMD Schmid Group N V	3.01	129.62M	0	0	0	0.00
JUNE Dhandho Junoon Etf	3.65	47.48M	0	0	0	0.00

Bionexus Gene Lab Corp Aktie (BGLC) Neueste Nachrichten

02:11 AM

IQVIA Holdings Inc. (NYSE:IQV) Receives $255.82 Consensus PT from Analysts - Defense World

02:11 AM

02:08 AM

BioNexus Gene Lab Receives Temporary Exception from Nasdaq Bid Price RuleOn December 27, 2024, BioNexus Gene Lab Corp. (NASDAQ:BGLC) announced in a recent 8-K filing that it has been granted a temporary exception by the Nasdaq Hearings Pa - Defense World

02:08 AM

02:07 AM

Silence Therapeutics Transitioning to U.S. Domestic Issuer Status - Defense World

02:07 AM

Jan 02, 2025

Stock market news: Neumora Therapeutics down by 80.75% while N2OFF surged by 333.47% during mid day trading - Business Upturn

Jan 02, 2025

Dec 28, 2024

Short Interest in ABVC BioPharma, Inc. (NASDAQ:ABVC) Rises By 148.2% - Defense World

Dec 28, 2024

Dec 27, 2024

BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Update - Defense World

Dec 27, 2024

Dec 20, 2024

BioNexus Gene Lab stock hits 52-week low at $0.22 - Investing.com

Dec 20, 2024

Dec 17, 2024

Critical Survey: BioNexus Gene Lab (NASDAQ:BGLC) versus MDxHealth (NASDAQ:MDXH) - Defense World

Dec 17, 2024

Dec 06, 2024

BioNexus Gene Lab Leads Our Top 3 US Penny Stocks - Simply Wall St

Dec 06, 2024

Dec 02, 2024

Stock market news: Senti Biosciences surge by 428.24% while Mondee Holdings plunged by 46.49% during mid day trading - Business Upturn

Dec 02, 2024

Nov 29, 2024

Thinking about buying stock in BioNexus Gene Lab, Gladstone Inve - GuruFocus.com

Nov 29, 2024

Nov 26, 2024

BGLC stock touches 52-week low at $0.28 amid sharp annual decline By Investing.com - Investing.com South Africa

Nov 26, 2024

BGLC stock touches 52-week low at $0.28 amid sharp annual decline - Investing.com Nigeria

Nov 26, 2024

Nov 16, 2024

BioNexus Gene Lab Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 16, 2024

Nov 15, 2024